Immuron Limited
IMRNNASDAQHealthcare● Active
$1.20
$-0.05(-4.00%)
Market Cap$7734846
P/E Ratio—
52W High$2.39
52W Low$0.677
Immuron Limited (IMRN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMRN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.29M | $4.90M | $1.80M | $0.77M | $0.15M |
| Cost of Revenue | $2.52M | $1.57M | $0.06M | $0.24M | $0.81M |
| Gross Profit | $4.77M | $3.34M | $1.74M | $0.52M | ($0.67M) |
| Gross Margin %(computed) | 65.39% | 68.06% | 96.42% | 68.41% | -456.22% |
| Operating Expenses | |||||
| R&D Expenses | $3.60M | $5.38M | $2.59M | $0.66M | $1.37M |
| G&A Expenses | $4.48M | $4.56M | $4.22M | $3.52M | $6.09M |
| Total Operating Expenses | $10.11M | $9.14M | $5.31M | $3.39M | $7.71M |
| Operating Income | ($5.34M) | ($5.80M) | ($3.57M) | ($2.87M) | ($8.38M) |
| Operating Margin %(computed) | -73.34% | -118.32% | -197.75% | -375.05% | — |
| Interest Income | $0.14M | $0.33M | $0.12M | $0.02M | $0.01M |
| Interest Expense | $0.01M | $0.01M | $0.01M | $0.01M | $0.01M |
| Income Before Tax | ($5.22M) | ($6.94M) | ($3.79M) | ($2.85M) | ($8.38M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($5.22M) | ($6.94M) | ($3.79M) | ($2.85M) | ($8.38M) |
| Net Margin %(computed) | -71.58% | -141.49% | -209.81% | -373.01% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.90 | $-1.22 | $-0.66 | $-0.50 | $-1.52 |
| Wtd Avg Shares | 5.77M | 5.70M | 5.69M | 5.69M | 5.53M |
| EBITDA | ($5.31M) | ($5.17M) | ($3.36M) | ($3.09M) | ($7.95M) |
| EBITDA Margin %(computed) | -72.83% | -105.45% | -186.19% | -403.92% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · AUD · M
Explore more Immuron Limited data
About Immuron Limited (IMRN) Income Statement
Immuron Limited (IMRN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IMRN reported revenue of $0.01B, gross profit of $0.00B (gross margin 65.39%), and net income of ($0.01B) — a net profit margin of -71.58%.
Frequently asked questions
IMRN · 4 questionsImmuron Limited (IMRN) reported revenue of $0.01B for 2025, up 48.6% year-over-year.
IMRN revenueIMRN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09